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Abstract
Background: During the 2009 influenza pandemic, individuals over the age of 60 had the lowest incidence of infection with
approximately 25% of these people having pre-existing, cross-reactive antibodies to novel 2009 H1N1 influenza isolates. It
was proposed that older people had pre-existing antibodies induced by previous 1918-like virus infection(s) that cross-
reacted to novel H1N1 strains.
Methodology/Principal Findings: Using antisera collected from a cohort of individuals collected before the second wave of
novel H1N1 infections, only a minority of individuals with 1918 influenza specific antibodies also demonstrated
hemagglutination-inhibition activity against the novel H1N1 influenza. In this study, we examined human antisera collected
from individuals that ranged between the ages of 1 month and 90 years to determine the profile of seropositive influenza
immunity to viruses representing H1N1 antigenic eras over the past 100 years. Even though HAI titers to novel 2009 H1N1
and the 1918 H1N1 influenza viruses were positively associated, the association was far from perfect, particularly for the
older and younger age groups.
Conclusions/Significance: Therefore, there may be a complex set of immune responses that are retained in people infected
with seasonal H1N1 that can contribute to the reduced rates of H1N1 influenza infection in older populations.
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Introduction
The influenza antigens hemagglutinin (HA) and neuraminidase
(NA) are the major surface glycoproteins of the virus and thus
immune protective targets. Changes (antigenic drift and shift) in
these HA and NA proteins can result in evasion of pre-existing
neutralizing antibodies within a host. Antigenic shifts led to 3
influenza pandemics over the last century resulting in significant
morbidity and mortality. The 1918 pandemic was the most severe,
killing up to 50 million people worldwide. The 1918 influenza
virus was recently reconstructed from preserved patient specimens
[1,2,3] and is similar in sequence to the swine H1N1 viruses from
that era [1]. Human H1N1 serotypes persisted as seasonal
influenza until 1957, when they were replaced by the H2N2 virus
[4]. In 1968, the H2N2 isolates were replaced in the human
population by viruses of the H3N2 subtype. In 1977, the H1N1
virus reappeared in human populations. Since then, H1N1 and
H3N2 influenza have been circulating together with influenza B
viruses among humans.
In April 2009, the first cases of novel influenza H1N1 were
identified in North America. Our group and others demonstrated
that of the ,65 million people that were infected in the United
States by the end of 2009, infection and disease were highest in
school-age children, and severe cases were underrepresented in
elderly adults [5,6,7,8,9]. Structural analysis of the HA shows
a conservation within antigenic regions of 1918 and 2009
pandemic HA proteins that is not present in contemporary
seasonal H1N1 viruses [10,11]. Antigenic similarities, together
with the abnormal protection from severe disease in the elderly
population, led to the hypothesis that exposure to 1918-like viruses
confers cross-protective immune responses to novel H1N1 isolates
[12,13]. Several studies have indicated cross-reactive antibodies to
the 2009 pandemic H1N1 viruses in elderly human populations
[14] with monoclonal antibodies derived from survivors of the
1918 pandemic able to cross-neutralize 2009 pandemic viruses
[15]. Additionally, direct evidence of the cross-protective efficacy
elicited by exposure to 1918-like viruses has been demonstrated in
small animal models [16,17]. Therefore, the view emerged that the
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2009 HA differed little from its 1918 ancestor with respect to the
antibody responses, and that exposure to seasonal H1N1 in the
early twentieth century could explain the observed protection of
older adults from the 2009 pandemic.
However, serological data collected between 2009 and 2011
shows that only a minority of individuals with 1918 influenza-
specific antibodies also recognized the novel H1N1 influenza [9].
Our group examined human sera from individuals ranging
between 1 month and 90 years of age [9]. Although antibody
reactivity toward the novel 2009 H1N1 viruses and the 1918
influenza viruses are correlated, this correlation is not extraordi-
narily strong. Furthermore, the age-dependences of particular
antibody reactivity and their relationships to each other are not
readily explained by simple models. These results do not support
the notion that the novel 2009 H1N1 influenza viruses are nearly
antigenically equivalent to the 1918 influenza viruses and suggest
a complex relationship between a life-long history of infection and
the resulting antibody profile. These results presented in this
report also have implications for pre-pandemic vaccine priming
for emerging influenza subtypes.
Results
Antibodies to Novel H1N1 Influenza
In late November, 2009, approximately 2–4 weeks after the
peak of the fall wave in Allegheny County, Pennsylvania, serum
samples were collected anonymously from 846 persons that ranged
in age from 1 month to 90 years of age [14]. As previously
described, the HAI titer was determined for each serum sample
collected ($1:40 HAI titer as positive) for the novel H1N1 isolate
A/California/7/2009 [9] or A/Mexico/4108/2009 (Fig. 1). The
percentage of HAI positive samples was highest for the very young
(10–19 year-olds and 0–9 year-olds) and very old (80–90 year-
olds). The test for trend demonstrated increasing seropositivity for
novel H1N1 among younger cohorts (p = 0.001). Examination of
sera with HAI high titers $1:320 reveals that the fraction of
individuals with high titers (orange and red regions in Fig. 1) is
highest among people born in the 1950s and 1960s and lowest
among the oldest age groups (1920s and 1930s).
1918 Influenza Antibody Cross-reactivity with Novel
H1N1 Influenza
If the novel 2009 virus and the 1918 virus are antigenically very
similar, as required by some explanations of pre-existing immunity
to the 2009 virus, we would expect a strong association between
serum positivity for one and positivity for the other. As previously
described [9], HAI titers ($1:40 HAI titer as positive) were
determined for 1918 and novel H1N1 viruses for each serum
sample collected from a cohort of people representing ages 1
month to 90 years of age for the novel H1N1 isolate A/California/
7/2009 [9] or A/Mexico/4108/2009 (Fig. 1). The relationship
between positivity for a novel H1N1 and for the 1918 virus (A/
South Carolina/1/1918) is presented in Fig. 2. The odds ratio is
greater than 1 (with p,0.05) for all birth decades other than the
1930s and 2000s (Fig. 2C), indicating that sera positive for one
virus are more likely to be positive for the other. Nonetheless, only
a fraction of the people with HAI antibodies against 1918 also had
antibodies that recognized novel H1N1 and vice versa. For
example, in sera collected from individuals born in the 1920s that
recognized the 1918 virus, only 38% of the sera also recognized
novel H1N1 (Fig. 2A). Although the two viruses are clearly related,
many serum samples are positive for one virus, but negative for the
other across all age groups. For the older cohorts, more than half
of those positive for the 1918 virus are negative for the 2009 virus,
suggesting that infection with 1918-like influenza need not elicit
antibodies that react with the 2009 virus. The association between
HAI positive titers is strongest for middle aged groups, whose
earliest H1N1 exposure would likely have been to a virus (or
vaccine) quite different from the 1918-like viruses.
Hemagglutinin-inhibition Antibody Profiles Against
H1N1 Influenza
These and other results suggest that an individual’s history of
exposure to influenza viruses bears a complex relationship to
protection from novel viruses. To explore this relationship, we
tested each serum sample for HAI activity against a panel of
human H1N1 influenza strains isolated during the past 100 years
in the context of the history of human influenza infections since
1918 (Fig. 3). Previously, our group tested this cohort for
seroprevalence against two seasonal H1N1 viruses [9] and
included those results in an expanded panel seasonal H1N1
isolates for analysis. Four of the H1N1 strains were isolated
between 1918 and 1957 and represent historical strains, whereas
four of the strains were isolated between 1986 and 2007 and
represent contemporary strains after the reintroduction of an
H1N1 that is co-circulating with H3N2, but before the novel 2009
H1N1 pandemic.
As indicated previously [14], high HAI activity against A/South
Carolina/1/1918 was rare except in the sample sets from the
1920s and 1930s. Sera with HAI activity against seasonal isolates
from 1991 to 2007 were generally most prominent in the youngest
(1990s and 2000s) cohorts (Fig. 4A). HAI activity against the 1986
virus was highest for those born in the 1980s and quite low for
those born in the 2000s. These observations are broadly
compatible with a simple model in which HAI activity toward
a virus reflects exposure to a fairly closely related virus.
Other aspects of HAI activity against the H1N1 virus panel are
not so simply explained. Few samples collected from any age
group recognized A/Puerto Rico/8/1934. HAI activity against
A/Fort Monmouth/1/1947 was low in those born in the 1980s
and later. Interestingly however, sera collected from those born in
the 1960s and 1970s have high titers to the 1947 isolate, while
these same individuals generally have low HAI activity against the
more recent A/Denver/1/1957 isolate (Fig. 4B). Furthermore,
many serum samples collected from individuals born in the 1980s
and 1990s had high antibody activity against this 1957 isolate.
There was no correlation between HAI titers against H3N2
viruses and H1N1 viruses (Fig. 4C). Approximately half of the
people born between 1920 and 1979 had HAI antibodies against
three contemporary H3N2 isolates tested. Younger people born in
the 1980s and 1990s had higher numbers of H3N2 HAI positive
samples (35–75%), with a decline in the number of positive
samples from people born in the 2000s, although ,55% of the
samples were H3N2 positive. Few individuals had cross-reactive
antibodies to A/Perth/16/2009 virus, which began circulating in
late 2010.
Relationships between Antibody Titers to Different
Viruses
To assess relationships between HAI reactivity against different
viruses, we computed rank-order correlations of antibody titers for
pairs of viruses in our panel. Correlations of the CA/07/09 titers
with the HAI titers for the other H1N1 viruses are shown in
Figure 5. For most age groups, the strongest correlation was to the
other novel 2009 H1N1 virus, MX/4108/09 titer (for the 1970s
the 1918 virus correlation is higher by a small amount). This is to
be expected because the two 2009 viruses, though not identical,
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are very similar (two amino acid differences in the HA1
sequences). Not unexpectedly, the next highest correlation was
to the HAI titer against the 1918 virus. However, for many age
groups, the novel 2009/1918 HAI titer correlation is only
moderate or weak, and for most cohorts, one or more seasonal
isolates have comparable or stronger correlations. Among the
weakest novel 2009/1918 HAI titer correlations were sera
collected from individuals born in the 1990s (0.38) and 2000s
(0.33), suggesting that a naı¨ve human immune system does not
produce strong cross-reactivity to the 1918 virus in response to the
novel 2009 H1N1 virus. For all cohorts, the novel H1N1
2009 HAI titer correlates with titers of isolates separated from
each other by decades of evolution. Correlations for all pairs of
isolates are presented for each age cohort in the Fig. S1 and S2.
These results exhibit additional moderate and strong correlations
for pairs of isolates separated by significant antigenic drift. Many
of these correlations are comparable to or stronger than the novel
2009/1918 HAI titer correlation for the same age group.
Discussion
The novel 2009 H1N1 influenza virus emerged in March, 2009
and rapidly spread around the world resulting in the first influenza
pandemic of the 21st century. Unlike the 1957 or 1968 influenza
pandemics, the 2009 pandemic was caused by a subtype of
influenza (H1N1) that was already circulating in the human
population. However, the sequence of the antigenically important
hemagglutinin protein of the novel 2009 H1N1 virus was quite
different from that of the circulating seasonal H1N1 strains,
reflecting decades of independent evolution in the two lineages,
since their divergence from a common ancestor. Thus, it might
seem surprising that substantial pre-existing immunity to the novel
H1N1 2009 virus was observed in older (though not necessarily
elderly) adults, and that many such individuals carried pre-existing
HAI antibodies that recognized the novel 2009 H1N1 virus. These
observations raised questions about cross-reactivity of human
antibodies and the relationship between the history of exposure to
viral variants and the resulting profile of antibody reactivity.
Our group has measured the HAI reactivity of human sera to
a panel of H1N1 isolates that includes the novel 2009 pandemic
virus, the 1918 virus, and representative seasonal isolates from
various eras ([9] and Fig. 3). Some aspects of these age-
dependencies appear straightforward. Reactivity toward the
1918 virus is strongest in the elderly, as might be expected. HAI
titers against the seasonal 2007 H1N1 isolate are highest for the
young, who are the most likely infected with recent H1N1 isolates,
and fairly low for other age groups. Titers against the 1986 isolate
are low for those in the youngest cohort, who were born too late to
be exposed to a similar virus, and antibodies to the 1947 isolate are
highest at middle age groups and low in those born in the 1980s
and later.
Other aspects of the pattern are more puzzling. Titers for the
1986 and 2007 isolates are low in those individuals born prior to
each of those years, but high HAI titers against the 1991 and 1999
isolates are commonly found among older people. High titers for
the 1947 virus can be found in sera collected from people born in
the 1960s and 1970s, yet these same individuals have low HAI
titers against the 1957 isolate (Fig. 3), which is similar to the post-
1977 seasonal H1N1 that these individuals would have been
exposed [18]. Furthermore, HAI titers for the 1957 isolate are
high among those born in the 1980s and 1990s that are low HAI
titers against the 1947 isolate.
There was a greater frequency of high HAI titers in the middle
age groups compared to those individuals born in the 1920s,
despite the somewhat higher frequency of HAI positive titers in the
older age group. This may reflect the higher incidence of novel
2009 H1N1 virus infection in the middle age groups: positivity due
to actual infection is likely associated with a higher HAI titer than
Figure 1. Fraction of sera positive for A/Mexico/4108/2009 (novel H1N1) influenza by HAI titer by decade of birth. The number of
serum samples was categorized by HAI titer per age group. Dark blue= 1:20; Light blue = 1:40; Green= 1:80; Yellow= 1:160; Orange= 1:320;
Red = 1:640.
doi:10.1371/journal.pone.0039435.g001
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Figure 2. Seropositivity (HAI$1:40) for both novel H1N1 and 1918 influenza by decade of birth. Panel (A): The percentage of serum
samples positive for A/California/07/2009 (novel H1N1) among those that were positive (red) or negative (blue) for 1918 influenza. Panel (B): The
percentage of serum samples positive for 1918 influenza among those that were positive (red) or negative (blue) for A/California/07/2009 (novel
H1N1) influenza. Panel (C): Odds ratio for seropositivity for the two antigens. In all three panels the error bars indicate 95% confidence intervals.
doi:10.1371/journal.pone.0039435.g002
Figure 3. Schematic representation of influenza A subtypes circulating in the human population since 1918. Each subtype (colored
boxes) and specific H1N1 strains used for analysis in this study are depicted chronologically.
doi:10.1371/journal.pone.0039435.g003
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positivity due to pre-existing antibodies. However, in addition to
natural exposure, vaccination might contribute to this effect.
Interestingly, approximately twice as many serum samples that
were positive for novel 2009 H1N1 were more likely to be positive
to $4 H1N1 tested in this study (Fig. 6). These factors, however,
do not explain why high titers are more common in the
intermediate groups than in the young. In fact, the higher rate
of infection among the young makes this difference more difficult
to explain. Presumably the few among the middle age groups who
were infected developed a more potent antibody response than
younger people who were infected, perhaps because of their
greater prior exposure to influenza viruses. These observations
hint at a complex relationship between viral exposures and
antibody profile.
It has been proposed that pre-existing antibodies to the novel
2009 H1N1 virus in older adults can be explained by their
exposure to 1918-like viruses in the early twentieth century [19].
Reports based on diverse lines of evidence have emphasized the
similarity of the 1918 and novel 2009 HA molecules from the
point of view of the immune system [10,11], perhaps leaving the
impression that they are practically equivalent. The results
presented in this report indicate a more complex picture. HAI
titers to the two antigens are undoubtedly positively associated
(Figs. 2 and 5). However, the association is far from perfect,
particularly for the older and younger cohorts. For most cohorts
the relationship appears even less impressive when compared to
the correlations between titers for the novel 2009 virus and later
seasonal viruses (Fig. 5). Overall, comparison of the HAI reactivity
against the HA antigens reveals additional moderate correlations
between viruses that would not be considered antigenically close
(Fig. S1 and S2). Many of these correlations are comparable to or
higher than the novel 2009/1918 correlation by age group, further
suggesting that the 1918 and novel 2009 hemagglutinin proteins
should not be regarded as nearly equivalent. Also, only the very
old would have been exposed to a close relative of the 1918 virus;
whereas individuals in other age groups would only have
experienced seasonal H1N1 viruses divergent from novel 2009
H1N1.
Both pre-existing antibodies to the novel 2009 H1N1 viruses
and some puzzling patterns in the results presented here may
reflect complex interactions between sequential exposures to
different, but related, viruses. The antibody response to an
influenza exposure may involve the activation of memory B cells
that are present because of an earlier exposure to a somewhat
different virus. Thus, earlier exposures can shape the antibody
response to later exposures. One manifestation of this phenom-
enon is ‘‘original antigenic sin’’: after an individual’s first exposure
to a subtype, subsequent exposures to variants tend to elicit
Figure 4. Seropositive samples for influenza A strains. The percentage of serum samples that were HAI positive per decade of birth were
identified for (A) historical Human H1N1 strains; 1934–1957, (B) contemporary Human H1N1 strains; 1986–2007, (C) Human H3N2 strains.
doi:10.1371/journal.pone.0039435.g004
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antibodies that react with the original virus, possibly at the expense
of reactivity toward the novel variant [20,21,22,23]. A beneficial
consequence of the phenomenon may be that sequential exposures
to drift variants lead to production of broadly protective
antibodies. Therefore, MBCs with broader specificities will be
disproportionately activated by drift variants and subsequent
somatic mutation and selection may increase breadth. Since older
individuals would have been exposed to a larger number of
influenza variants, this might explain the age-dependent occur-
rence of pre-existing antibodies to novel H1N1 and the relation-
ship between age and disease severity.
Materials and Methods
Viruses
Prototype strains chosen for this study were representative of
antigenically distinct human seasonal influenza A H1N1 viruses in
circulation during separate periods spanning nearly nine decades.
Allantoic fluid antigens from influenza A/Brisbane/59/2007, A/
New Caledonia/20/1999, A/Texas/36/1991, A/Singapore/6/
1986, A/Denver/1/1957, A/Fort Monmouth/l/1947, A/Puerto
Rico/8/1934, as well as the sequences based upon A/South
Carolina/1/1918 isolate to generate virus-like particles (VLP)
[9,24]. Novel H1N1 isolates, A/California/7/2009 and A/
Mexico/4108/2009, were used as representative isolates, as well
as three H3N2 viruses, A/Wyoming/3/2003 and A/Sydney/5/
1997. Influenza viruses were prepared by propagating virus in
embryonated eggs as previously described.
Sample Cohorts and Collections
Serum specimens used for this analysis have been previously
described [14]. Briefly, serum samples were collected anony-
mously from extra laboratory specimens from mid-November to
early December 2009. Anonymous blood samples were obtained
from clinical laboratories and categorized by decade of birth
from 1920–2009. Using hemagglutination-inhibition assays,
approximately 100 samples per decade (n = 846) were tested
from blood samples drawn on hospital and clinic patients.
University of Pittsburgh IRB approval [(exempt)
#PRO09110164] was obtained. Blood samples were collected
using the honest broker system at the University of Pittsburgh
Medical Center and Children’s Hospital of Pittsburgh labora-
tories and given to investigators organized by decade of birth
without other identifying information. The human serum
Figure 5. Correlations of CA/07/09 antibody titers with titers for other H1N1 isolates. The rank-order correlation coefficient between the
CA/07/09 HAI titer and each other H1N1 titer is displayed for each decade of birth. As indicated at the right of the figure, warmer colors correspond
to higher correlation coefficients.
doi:10.1371/journal.pone.0039435.g005
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samples were obtained from discarded blood collections at the
following primary care medical visits. The samples had no
identifying information, except decade of birth, and no other
information was obtained. Each serum sample was tested in
hemagglutination-inhibition assay (HAI) against two pandemic
H1N1 (A/California/7/2009 and A/Mexico/4108/2009), as
well as a panel of seasonal H1N1 isolates. Reference sera from
individuals vaccinated with either inactivated trivalent seasonal
Fluzone vaccine or pandemic H1N1 FluMist (GSK) vaccines
were used as positive controls.
Hemagglutination Inhibition Assay
The hemagglutination inhibition (HAI) assay was used to assess
functional antibodies to the HA able to inhibit agglutination of
turkey erythrocytes. The protocol was adapted from the CDC
laboratory-based influenza surveillance manual as previously
described [25]. To inactivate non-specific inhibitors, sera were
treated with receptor destroying enzyme (RDE) prior to being
tested [26,27,28,29,30]. The HAI titer was determined by the
reciprocal dilution of the last well which contained non-
agglutinated RBC. Positive and negative serum controls were
included for each plate. HAI titers per group reflect appropriate
estimates with 95% confidence intervals shown (by Clopper-
Pearson method), along with plots showing odds ratios with 95%
confidence limits (calculated using the ‘‘fisher.test’’ function of the
R statistical package). For the correlations, Spearman’s rank-order
correlation coefficient were calculated.
Supporting Information
Figure S1 Heat Map of antibody positivity by decade of
birth for each H1N1 isolate listed. Lighter colors indicate
positive antibody titer per sample.
(TIF)
Figure 6. Seropositivity (HAI$1:40) for multiple seasonal H1N1 influenza viruses by decade of birth. Panel (A): The percentage of serum
samples positive for A/California/07/2009 (novel H1N1) among those that were positive for $4 seasonal H1N1 (red) or positive for ,4 seasonal H1N1
(blue). Panel (B): The percentage of serum samples positive for $4 seasonal H1N1 influenza viruses among those that were positive (red) or negative
(blue) for A/California/07/2009 (novel H1N1) influenza. Panel (C): Odds ratio for seropositivity for A/California/07/2009 and seropositivity for $4
seasonal H1N1 influenza viruses. In all three panels the error bars indicate 95% confidence intervals.
doi:10.1371/journal.pone.0039435.g006
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Figure S2 Correlations of CA/07/09 antibody titers
with titers for other H1N1 isolates. The rank-order
correlation coefficient between the CA/07/09 HAI titer and each
other H1N1 titer is displayed for each decade of birth. As
indicated at the right of the figure, warmer colors correspond to
higher correlation coefficients.
(TIF)
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